| scholarly article | Q13442814 |
| P50 | author | Eva-Maria Mandelkow | Q19971785 |
| P2093 | author name string | Thomas Timm | |
| Annika Eikhof | |||
| Cindy Hempp | |||
| Dorthe Matenia | |||
| P2860 | cites work | PINK1 is selectively stabilized on impaired mitochondria to activate Parkin | Q21145802 |
| MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1 | Q24296268 | ||
| PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility | Q24296955 | ||
| PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 | Q24297155 | ||
| Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability | Q24299939 | ||
| Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1) | Q24307730 | ||
| LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1 | Q24310603 | ||
| Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons | Q24311721 | ||
| PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1 | Q24312106 | ||
| MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption | Q24313701 | ||
| The kinase domain of mitochondrial PINK1 faces the cytoplasm | Q24321709 | ||
| PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons | Q24322788 | ||
| Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 | ||
| PINK1 protein in normal human brain and Parkinson's disease | Q24337151 | ||
| PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin | Q24530623 | ||
| The yeast par-1 homologs kin1 and kin2 show genetic and physical interactions with components of the exocytic machinery | Q24557447 | ||
| Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates | Q27860715 | ||
| Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress | Q28592727 | ||
| Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin | Q29547423 | ||
| Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL | Q29615624 | ||
| The PINK1/Parkin pathway regulates mitochondrial morphology | Q29615641 | ||
| Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin | Q29615684 | ||
| Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin | Q29622838 | ||
| Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder | Q33344464 | ||
| Structural determinants of PINK1 topology and dual subcellular distribution | Q33751996 | ||
| Parkinson's disease: insights from pathways | Q33871291 | ||
| Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control | Q34805850 | ||
| Macroautophagy--a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease | Q36320351 | ||
| Cytoplasmic Pink1 activity protects neurons from dopaminergic neurotoxin MPTP. | Q36446511 | ||
| Characterization of PINK1 processing, stability, and subcellular localization | Q36802214 | ||
| Functions and dysfunctions of mitochondrial dynamics | Q36967747 | ||
| Pink1 forms a multiprotein complex with Miro and Milton, linking Pink1 function to mitochondrial trafficking | Q37219276 | ||
| Axonal transport and the delivery of pre-synaptic components | Q37308044 | ||
| Dependence of leucine-rich repeat kinase 2 (LRRK2) kinase activity on dimerization | Q37479332 | ||
| The tau of MARK: a polarized view of the cytoskeleton | Q37533083 | ||
| Mitophagy and Parkinson's disease: the PINK1-parkin link. | Q37587126 | ||
| PINK1 function in health and disease | Q37668218 | ||
| Mitophagy: the latest problem for Parkinson's disease | Q37819135 | ||
| Molecular mechanisms of PINK1-related neurodegeneration | Q37844466 | ||
| PINK1 controls mitochondrial localization of Parkin through direct phosphorylation | Q39924212 | ||
| Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1. | Q40051916 | ||
| The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. | Q40074115 | ||
| Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2/Par-1. | Q40158901 | ||
| C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. | Q40285081 | ||
| Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. | Q40361843 | ||
| Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress | Q41830251 | ||
| Structure of the catalytic and ubiquitin-associated domains of the protein kinase MARK/Par-1. | Q42680195 | ||
| Drosophila Miro is required for both anterograde and retrograde axonal mitochondrial transport. | Q43099615 | ||
| Axonal mitochondrial transport and potential are correlated | Q44901240 | ||
| Glycogen synthase kinase (GSK) 3beta directly phosphorylates Serine 212 in the regulatory loop and inhibits microtubule affinity-regulating kinase (MARK) 2. | Q46634959 | ||
| Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism | Q48742196 | ||
| Interactions of MAP/microtubule affinity regulating kinases with the adaptor complex AP-2 of clathrin-coated vesicles. | Q51778634 | ||
| Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. | Q53246695 | ||
| Mitochondrial dysfunction in Parkinson's disease | Q60290965 | ||
| Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles | Q60603637 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 8174-8186 | |
| P577 | publication date | 2012-01-11 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Microtubule affinity-regulating kinase 2 (MARK2) turns on phosphatase and tensin homolog (PTEN)-induced kinase 1 (PINK1) at Thr-313, a mutation site in Parkinson disease: effects on mitochondrial transport | |
| P478 | volume | 287 |
| Q34046913 | An old molecule with a new role: microtubules in inflammasome regulation |
| Q38014338 | Analysis of the regulatory and catalytic domains of PTEN-induced kinase-1 (PINK1). |
| Q37590635 | Back to the tubule: microtubule dynamics in Parkinson's disease |
| Q34379744 | Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through protein kinase A |
| Q36636038 | Characterization of PINK1 (PTEN-induced putative kinase 1) mutations associated with Parkinson disease in mammalian cells and Drosophila |
| Q36810811 | Cytosolic PINK1 promotes the targeting of ubiquitinated proteins to the aggresome-autophagy pathway during proteasomal stress |
| Q27021874 | Emerging modes of PINK1 signaling: another task for MARK2 |
| Q64109825 | Epigenetically dysregulated genes and pathways implicated in the pathogenesis of non-syndromic high myopia |
| Q38093581 | Function and characteristics of PINK1 in mitochondria |
| Q47162391 | Identification of Ser465 as a novel PINK1 autophosphorylation site |
| Q38730062 | Impairment of mitochondria dynamics by human A53T α-synuclein and rescue by NAP (davunetide) in a cell model for Parkinson's disease. |
| Q36479159 | In Vitro Comparison of the Activity Requirements and Substrate Specificity of Human and Triboleum castaneum PINK1 Orthologues |
| Q51612042 | MARK2 Rescues Nogo-66-Induced Inhibition of Neurite Outgrowth via Regulating Microtubule-Associated Proteins in Neurons In Vitro. |
| Q91906793 | Memantine Improves Cognitive Function and Alters Hippocampal and Cortical Proteome in Triple Transgenic Mouse Model of Alzheimer's Disease |
| Q38179990 | Mitochondria dynamism: of shape, transport and cell migration |
| Q38021865 | Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences |
| Q24337079 | Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease |
| Q91839477 | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation |
| Q64779288 | PINK1 Interacts with VCP/p97 and Activates PKA to Promote NSFL1C/p47 Phosphorylation and Dendritic Arborization in Neurons |
| Q42321011 | PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival. |
| Q24310717 | PINK1 kinase catalytic activity is regulated by phosphorylation on serines 228 and 402 |
| Q58195575 | PTMD: A Database of Human Disease-associated Post-translational Modifications |
| Q35746162 | Parkinson's Disease in Saudi Patients: A Genetic Study |
| Q57028935 | Proteomic Investigation of Murine Neuronal α7-Nicotinic Acetylcholine Receptor Interacting Proteins |
| Q58716523 | Reduction of PINK1 or DJ-1 impair mitochondrial motility in neurites and alter ER-mitochondria contacts |
| Q37093852 | Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease |
| Q47379543 | Structure of PINK1 in complex with its substrate ubiquitin. |
| Q94527498 | The inhibition of MARK2 suppresses cisplatin resistance of osteosarcoma stem cells by regulating DNA damage and repair |
| Q48124425 | Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies |
Search more.